Teva Pharmaceutical Industries (NYSE:TEVA) reported its Q4 earnings results on Wednesday, February 9, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Check out this: Executives Buy Around $64M Of 3 Stocks
Earnings
Teva Pharmaceutical Indus beat estimated earnings by 5.48%, reporting an EPS of $0.77 versus an estimate of $0.73.
Revenue was up $354.00 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.06, which was followed by a 2.24% drop in the share price the next day.
Here's a look at Teva Pharmaceutical Indus's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 0.65 | 0.59 | 0.59 | 0.63 |
| EPS Actual | 0.59 | 0.59 | 0.63 | 0.68 |
| Revenue Estimate | 4.03B | 4.04B | 4.02B | 4.37B |
| Revenue Actual | 3.89B | 3.91B | 3.98B | 4.45B |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
